Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

被引：0
|
作者：
Park, Deborah Y. [1 ]
Poudel, Shyam K. [2 ]
Jia, Xuefei [3 ]
Wilks, Mailey Lynn [2 ]
Pinkava, Vicki [2 ]
O'Brien, Meghan [2 ]
Tripp, Barbara [2 ]
Song, Jung-Min [2 ]
McCrae, Keith R. [2 ]
Angelini, Dana E. [2 ]
Khorana, Alok A. [2 ]
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland Hts, OH USA
[2] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1237
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain
    Munoz, Andres
    Gallardo, Enrique
    Agnelli, Giancarlo
    Crespo, Carlos
    Forghani, Monica
    Arumi, Daniel
    Fernandez de Cabo, Susana
    Soto, Javier
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 840 - 847
  • [2] Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
    Yhim, Ho-Young
    Bang, Soo-Mee
    BLOOD RESEARCH, 2014, 49 (02) : 77 - 79
  • [3] Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
    Masini, Marta
    Toma, Matteo
    Spallarossa, Paolo
    Porto, Italo
    Ameri, Pietro
    CURRENT ONCOLOGY REPORTS, 2023, 25 (09) : 979 - 987
  • [4] Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
    Marta Masini
    Matteo Toma
    Paolo Spallarossa
    Italo Porto
    Pietro Ameri
    Current Oncology Reports, 2023, 25 : 979 - 987
  • [5] Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants
    Ay, C.
    Beyer-Westendorf, J.
    Pabinger, I.
    ANNALS OF ONCOLOGY, 2019, 30 (06) : 897 - 907
  • [6] Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?
    Jennifer Howlett
    Eric Benzenine
    Philippe Fagnoni
    Catherine Quantin
    Journal of Thrombosis and Thrombolysis, 2020, 50 : 642 - 651
  • [7] Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?
    Howlett, Jennifer
    Benzenine, Eric
    Fagnoni, Philippe
    Quantin, Catherine
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (03) : 642 - 651
  • [8] Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
    Recio-Boiles, Alejandro
    Veeravelli, Sumana
    Vondrak, Jessica
    Babiker, Hani M.
    Scott, Aaron J.
    Shroff, Rachna T.
    Patel, Hitendra
    Elquza, Emad
    McBride, Ali
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (10) : 866 - 876
  • [9] Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
    Alejandro Recio-Boiles
    Sumana Veeravelli
    Jessica Vondrak
    Hani M Babiker
    Aaron J Scott
    Rachna T Shroff
    Hitendra Patel
    Emad Elquza
    Ali McBride
    World Journal of Gastrointestinal Oncology, 2019, 11 (10) : 866 - 876
  • [10] Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats
    O'Connell, Casey
    Escalante, Carmen P.
    Goldhaber, Samuel Z.
    McBane, Robert
    Connors, Jean M.
    Raskob, Gary E.
    ONCOLOGIST, 2021, 26 (01): : E8 - E16
12345